Clinical Trials Logo

Clinical Trial Summary

When receiving adjuvant chemotherapy, a variety of symptoms will appear and it is very painful. These symptoms occur at the same time and are related to each other. The symptom distress may affect the patient's compliance with adjuvant chemotherapy and whether the adjuvant chemotherapy can be completed on schedule. Among the symptoms of trouble, cancer-related fatigue is the most common, and the incidence can be as high as 99%. In this study, I want to track the population of breast cancer patients receiving adjuvant chemotherapy, and women in the control group who receive only anti-hormonal breast cancer or carcinoma in situ. During the treatment period, at different time points, it also collects subjective symptom distress changes and changes. The study aimed cancer-related exhaustion is measured to gain a deeper understanding of the effects of symptom troubles suffered by patients during treatment. We also hoped that in the future, it can be provided to colleagues in clinical work and can be given to breast cancer patients receiving adjuvant chemotherapy and increased holistic care quality.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04911699
Study type Observational
Source Taipei Medical University
Contact Tsai-Wei Huang, PhD
Phone +88627361661
Email tsaiwei@tmu.edu.tw
Status Not yet recruiting
Phase
Start date May 29, 2021
Completion date July 31, 2024